Placeholder text
Bench to Bedside
0 - Default Title
Description
In Bench to Bedside: The Business of Drug Development, Fraser Gibson takes readers inside this world, tracing the journey of a new therapy from the laboratory bench to the patient's bedside. Along the way, he explains why developing a single drug can take over a decade, cost billions, and still end in failure, and why so many promising discoveries never make it to market.
Readers will discover: ¿ Why drug development is so costly, lengthy, and uncertain ¿ The roles of scientists, regulators, pharmaceutical companies, and patients in bringing therapies to life ¿ How digital health tools and artificial intelligence are changing the research landscape ¿ What the future of innovation might mean for medicine and society
Bench to Bedside offers a grounded and accessible look at one of the world's most vital and often misunderstood industries. It reminds readers that behind every therapy lies not just data and dollars, but people, innovation, and the ongoing pursuit of better health for all.
Product details
Binding:
Paperback
Number of Pages:
264
Release Date:
2026-02-11
Publication Date:
2026-02-11
Publisher:
FriesenPress
Languages:
Original:
English
ISBN10:
1038350921
ISBN13:
9781038350923
GPSR Manufacturer Reference:
Weight:
434 g
Height:
152 cm
Width:
229 cm
Thickness:
16 cm
Currently sold out